Immunology

Items 11-20 of 27

Page
per page
Set Descending Direction
  1. PARG (human) (rec.) (His) (active) (10µg)
    BBL-2285
    BBL-2285-C01010 µg
    CHF 782.00
    PARG (human) (rec.) (His) (active) (10µg)
  2. PARG (human) (rec.) (His) (active) (1µg)
    BBL-2283
    BBL-2283-C0011 µg
    CHF 441.00
    PARG (human) (rec.) (His) (active) (1µg)
  3. PD-1 (human) ELISA Kit
    AG-45B-0015
    AG-45B-0015-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  4. PD-L1 (human) ELISA Kit
    AG-45B-0016
    AG-45B-0016-KI0196 wells
    CHF 610.00
    Figure: Specific quantitation of APRIL in human serum.
Method: Serum from a healthy patient is left untreated or treated with 1µg/ml of the APRIL receptor, TACI (human):Fc (human) (Prod. No. AG-40B-0079). APRIL levels were measured us
  5. RIG-I (human) (rec.) (His) (active) (10µg)
    BBL-2291
    BBL-2291-C01010 µg
    CHF 600.00
    NEW RIG-I (human) (rec.) (His) (active) (10µg)
  6. RIG-I (human) (rec.) (His) (active) (50µg)
    BBL-2294
    BBL-2294-C05050 µg
    CHF 999.00
    NEW RIG-I (human) (rec.) (His) (active) (50µg)
  7. RIG-I ATPase FI Assay System
    BBL-3035-FI
    BBL-3035-FI-1K1000 assays
    CHF 927.00
    BBL-3035-FI-10K10000 assays
    CHF 4'673.00
    BBL-3035-FI-100K10 x 10000 assaysINQ
    NEW RIG-I ATPase FI Assay System
  8. Selumetinib
    CAS  606143-52-6
    AG-CR1-3757
    AG-CR1-3757-M01010 mg
    CHF 30.00
    AG-CR1-3757-M05050 mg
    CHF 80.00
    Selumetinib

Items 11-20 of 27

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.